FIELD: medicine.
SUBSTANCE: transforming growth stimulation factor beta 1 (TGFβ1) is determined in the fluid taken from an anterior eye chamber. If the measured level is less than 1,000 pg/ml, organ-specific self-immunisation is predicted.
EFFECT: using the invention provides the early detection of an self-immunising component or process accompanying inflammatory eye disorders with increasing diagnostic accuracy and choosing an adequate therapeutic approach.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING HIGH RISK OF AUTOIMMUNE INFLAMMATION IN POST-TRAUMATIC UVEITIS IN LONG TERM | 2021 |
|
RU2754292C1 |
METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF CHRONIC POST-TRAUMATIC UVEITIS AFTER SINGLE PENETRATING SURGICAL INTERVENTION ON EYEBALL | 2020 |
|
RU2733745C1 |
METHOD OF DETERMINING SPECIFIC SENSITIZATION TO MEMBRANES OF EYE | 2023 |
|
RU2806032C1 |
METHOD FOR PREDICTING RISK OF RETINAL DETACHMENT DEVELOPMENT IN CASES OF PERIPHERAL AND POSTERIOR UVEITES IN CHILDREN | 2000 |
|
RU2172957C1 |
METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
METHOD OF TREATMENT OF CENTRAL CORNEAL ULCERS OF BACTERIAL AND HERPETIC ETIOLOGY | 2018 |
|
RU2668713C1 |
METHOD FOR TREATING POSTOPERATIVE UVEITIS CASES | 2006 |
|
RU2307653C1 |
METHOD OF INFLAMMATORY COMPLICATIONS FORECASTING WITHIN REPEATED EYE SURGICAL INTERVENTIONS | 2006 |
|
RU2330614C1 |
METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS | 2005 |
|
RU2298188C1 |
METHOD FOR PREDICTING UVEITIS DEVELOPMENT COURSE IN THE CASES OF SYSTEMIC OR SYNDROMIC DISEASES | 1999 |
|
RU2157541C1 |
Authors
Dates
2015-10-10—Published
2014-12-11—Filed